Peter Shaw

Peter Shaw is an experienced scientist currently serving as the Head of Clinical Pharmacogenetics at Merck. With a PhD in Drug Metabolism from the University of Aberdeen, they have a robust background in biomarker and genomic platform development throughout drug discovery. Their previous positions include leadership roles at Bristol Myers Squibb and NYU Langone Medical Center, where they managed multi-disciplinary teams and conducted genetic analyses across various therapeutic areas. Peter is dedicated to advancing personalized medicine and has a strong track record in regulatory interactions and strategic partnerships with academic and biotechnology organizations.